Mydriasis
Showing 1 - 25 of 189
Aphakia, Mydriasis Trial in Changzhou (Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage
Recruiting
- Aphakia
- Mydriasis
- Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage Pupilloplasty
-
Changzhou, Jiangsu, ChinaPreoperatively and 6 Months Postoperatively
Apr 12, 2023
Mydriasis, Dilation Trial in United States (Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine Mesylate Ophthalmic
Completed
- Mydriasis
- Dilation
- Phentolamine Mesylate Ophthalmic Solution 1%
- Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
-
Pittsburg, Kansas
- +3 more
Aug 11, 2022
Mydriasis, Dilation Trial in Longwood, Athens (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle
-
Longwood, Florida
- +1 more
Jun 20, 2022
Mydriatic Eye Drops in Retinopathy of Prematurity Examinations
Completed
- Retinopathy of Prematurity
- +3 more
- NIRS(INVOS 5100; Covidien Somanetics, Troy, MI
-
Istanbul, TurkeyIstanbulTRH
May 19, 2023
Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle)
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle
-
Newport Beach, California
- +14 more
Jun 20, 2022
Hearing Loss Trial in New York (Electrical stimulator)
Not yet recruiting
- Hearing Loss
- Electrical stimulator
-
New York, New YorkNYU Langone Health
May 12, 2023
Cataract Trial in Graz (Eye injection (Mydrane), eye drops (Phenylephrin), eye drops (Tropicamid))
Completed
- Cataract
- Eye injection (Mydrane)
- +2 more
-
Graz, AustriaMedical University Graz
Oct 11, 2021
Mydriasis Trial in Cypress (Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE), Tropicamide 1% ophthalmic solution
Completed
- Mydriasis
- Tropicamide 1%-Phenylephrine 2.5% ophthalmic solution (TR/PE)
- +2 more
-
Cypress, CaliforniaWCCT
Mar 16, 2022
Mydriasis Trial in Austin, San Antonio (Tropicamide/Phenylephrine ophthalmic solution (TR/PE), Placebo)
Completed
- Mydriasis
- Tropicamide/Phenylephrine ophthalmic solution (TR/PE)
- Placebo
-
Austin, Texas
- +1 more
Mar 16, 2022
Efficacy of the Nanodropper Device on Pupillary Dilation
Completed
- Dilation
- Nanodropper
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 9, 2022
Pain, Monitoring, Intraoperative Trial in Edegem (PDR measurement)
Completed
- Pain
- Monitoring, Intraoperative
- PDR measurement
-
Edegem, Antwerp, BelgiumUniversity hospital Antwerp
May 17, 2022
Pain Trial in Vitoria-Gasteiz (Pupillometer)
Active, not recruiting
- Pain
- Pupillometer
-
Vitoria-Gasteiz, Álava, SpainAraba University hospital
Mar 10, 2022
Mydriasis, Dilation Trial in United States (Phentolamine Ophthalmic Solution 0.75%, Phentolamine Ophthalmic Solution Vehicle
Completed
- Mydriasis
- Dilation
- Phentolamine Ophthalmic Solution 0.75%
- Phentolamine Ophthalmic Solution Vehicle (Placebo)
-
Newport Beach, California
- +11 more
Mar 17, 2021
Retinopathy of Prematurity Trial (0.5% cyclopentolate and 2.5% phenylephrine, 0.5% tropicamide + 0.5% phenylephrine, 0.5%
Completed
- Retinopathy of Prematurity
- 0.5% cyclopentolate and 2.5% phenylephrine
- +2 more
- (no location specified)
Apr 8, 2021
Pain, Acute, Anesthesia Trial in Edegem (Pupillary dilation reflex, Standard of care)
Recruiting
- Pain, Acute
- Anesthesia
- Pupillary dilation reflex
- Standard of care
-
Edegem, Antwerp, BelgiumUniversity hospital Antwerp
Apr 27, 2021
Critical Illness Trial in Edegem (Measurement of NFR and PDR)
Recruiting
- Critical Illness
- Measurement of NFR and PDR
-
Edegem, Antwerpen, BelgiumUniversity hospital Antwerp
Apr 27, 2021
Corneal Endothelial Cell Loss, Mydriasis, Cataract Trial in Cairo (Fydrane®: (Manufacturer DELPHARM TOURS, FRANCE).)
Completed
- Corneal Endothelial Cell Loss
- +2 more
- Fydrane®: (Manufacturer DELPHARM TOURS, FRANCE).
-
Cairo, EgyptCairo University - Kasr Alainy hospital
May 19, 2020
Hyperemia Eye Trial (Naphazoline / Hypromellose Ophthalmic)
Not yet recruiting
- Hyperemia Eye
- Naphazoline / Hypromellose Ophthalmic
- (no location specified)
Jul 22, 2022
Cataract Trial in Baltimore (Topical phenylephrine 2.5%, Topical cyclopentolate 1%, Intracameral Lidocaine 1%)
Terminated
- Cataract
- Topical phenylephrine 2.5%
- +3 more
-
Baltimore, MarylandWilmer Eye Institute, Johns Hopkins
Aug 22, 2019
Pupil Dilation Before Laser-assisted Cataract Surgery
Unknown status
- Cataract Surgery
- cyclopentolate 0.5% eye drops
-
Reims, FranceChu Reims
Dec 13, 2019
Retinopathy of Prematurity Trial in Thessaloníki (Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%,
Recruiting
- Retinopathy of Prematurity
- Microdrop administration of phenylephrine 1.67% and tropicamide 0.33%
- Standard drop administration of phenylephrine 1.67% and tropicamide 0.33%
-
Thessaloníki, GreecePapageorgiou General Hospital
Oct 14, 2021
Cataract Surgery Trial in Roma (Efficacy of a Standardized Intracameral Combination of Mydriatics and Anesthetic (Mydrane ®) for
Completed
- Cataract Surgery
- Efficacy of a Standardized Intracameral Combination of Mydriatics and Anesthetic (Mydrane ®) for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma
-
Roma, ItalyPoliclinico Gemelli
Jul 4, 2023
Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML
Withdrawn
- Wet Macular Degeneration
- Aflibercept 40 MG/ML [Eylea]
- +2 more
-
Prague, CzechiaDepartment of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022
Retinopathy of Prematurity Trial in Thessaloníki (Microdrop administration [phenylephrine 1.67% + tropicamide 0.33% (drop
Completed
- Retinopathy of Prematurity
- Microdrop administration [phenylephrine 1.67% + tropicamide 0.33% (drop volume: 6-7 μL)]
- Standard drop administration [phenylephrine 1.67% + tropicamide 0.33% (drop volume: 28-34 μL)]
-
Thessaloníki, Greece"Papageorgiou" General Hospital
Mar 23, 2022